Elm Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Elm Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-650	Closed	-$18K	–	291
2018 Q3	$18K	Buy	+650	New	+$18.3K	0.01%	234

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elm Advisors's NXTM Position: Q4 2018 in Review

Elm Advisors sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 650 shares — an estimated $18K sold.

Elm Advisors first reported a position in NXTM in Q3 2018 and held it in 1 quarter. The position peaked at $18K in Q3 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

Elm Advisors reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
Elm Advisors sold 650 NxStage Medical Inc. shares in Q4 2018, an estimated $18K.
Elm Advisors first reported a position in NxStage Medical Inc. in Q3 2018 and held it in 1 quarter.
Elm Advisors's NxStage Medical Inc. position peaked at $18K in Q3 2018.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Elm Advisors's 13F filing for Q4 2018, filed 8 Jan 2019.